EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Capital Work in Progress History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹21 Cr | ₹19 Cr | ₹9.49 Cr | ₹8.03 Cr | ₹0.08 Cr |
What is the latest Capital Work in Progress ratio of EVEREST ORGANICS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹21 Cr |
| Mar2024 | ₹19 Cr |
| Mar2023 | ₹9.49 Cr |
| Mar2022 | ₹8.03 Cr |
| Mar2021 | ₹0.08 Cr |
How is Capital Work in Progress of EVEREST ORGANICS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹21 Cr | 10.46 | |
| Mar2024 | ₹19 Cr | 103.86 | |
| Mar2023 | ₹9.49 Cr | 18.18 | |
| Mar2022 | ₹8.03 Cr | 10,606.67 | |
| Mar2021 | ₹0.08 Cr | - | |
Compare Capital Work in Progress of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹289.0 Cr | -2% | -12.4% | -5.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -2% |
-12.4% |
-5.3% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses